Afficher la notice abrégée

dc.contributor.authorAyuda Durán, María Begoña 
dc.contributor.authorGarzón García, Lidia 
dc.contributor.authorGonzález Manzano, Susana 
dc.contributor.authorSantos Buelga, Celestino 
dc.contributor.authorGonzález Paramás, Ana M.
dc.date.accessioned2025-01-23T08:37:54Z
dc.date.available2025-01-23T08:37:54Z
dc.date.issued2024
dc.identifier.citationAyuda-Durán, B., Garzón-García, L., González-Manzano, S., Santos-Buelga, C., & González-Paramás, A. M. (2024). Insights into the Neuroprotective Potential of Epicatechin: Effects against Aβ-Induced Toxicity in Caenorhabditis elegans. Antioxidants, 13(1), 79. https://doi.org/10.3390/antiox13010079es_ES
dc.identifier.urihttp://hdl.handle.net/10366/162324
dc.descriptionThis research was financed by Grant PID2019-106167RB-I00 funded by MCIN/AEI/ 10.13039/501100011033, Consejería de Educación (Project SA093P20), and Strategic Research Programs for Units of Excellence from Junta de Castilla y León (ref. CLU-2018-04). Lidia Garzón-García was financed by Grant PRE2020-095876 associated to the project MCIN/AEI/ 10.13039/501100011033 and by “ESF Investing in your future”. Financiadores National Institutes of Health United States P40 OD010440 European Social Fund Plus European Union Consejería de Educación, Junta de Castilla y León Spain SA093P20es_ES
dc.description.abstractMedical therapies to avoid the progression of Alzheimer’s disease (AD) are limited to date. Certain diets have been associated with a lower incidence of neurodegenerative diseases. In particular, the regular intake of foods rich in polyphenols, such as epicatechin (EC), could help prevent or mitigate AD progression. This work aims to explore the neuroprotective effects of EC using different transgenic strains of Caenorhabditis elegans, which express human Aβ1-42 peptides and contribute to elucidating the mechanisms involved in the effects of EC in AD. The performed assays indicate that this flavan-3-ol was able to reduce the signs of β-amyloid accumulation in C. elegans, improving motility and chemotaxis and increasing survival in transgenic strain peptide producers compared to nematodes not treated with EC. The neuroprotective effects exhibited by EC in C. elegans could be explained by the modulation of inflammation and stress-associated genes, as well as autophagy, microgliosis, and heat shock signaling pathways, involving the regulation of cpr-5, epg-8, ced-7, ZC239.12, and hsp-16 genes. Overall, the results obtained in this study support the protective effects of epicatechin against Aβ-induced toxicity.es_ES
dc.language.isoenges_ES
dc.publisherhttps://www.mdpi.com/2076-3921/13/1/79es_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectneuroprotectiones_ES
dc.subjectflavonoidses_ES
dc.subjectchemotaxises_ES
dc.subjectgene expressiones_ES
dc.subjectparalysises_ES
dc.subject.meshChemotaxis *
dc.subject.meshFlavonoids *
dc.subject.meshGene Expression *
dc.subject.meshParalysis *
dc.titleInsights into the neuroprotective potential of epicatechin: effects against Aβ-Induced toxicity in caenorhabditis eleganses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://doi.org/10.3390/antiox13010079es_ES
dc.identifier.doi10.3390/ANTIOX13010079
dc.rights.accessRightsinfo:eu-repo/semantics/embargoedAccesses_ES
dc.identifier.essn2076-3921
dc.journal.titleAntioxidantses_ES
dc.volume.number13es_ES
dc.issue.number1es_ES
dc.page.initial79es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decsflavonoides *
dc.subject.decsquimiotaxis *
dc.subject.decsexpresión génica *
dc.subject.decsparálisis *
dc.description.projectThis research was financed by Grant PID2019-106167RB-I00 funded by MCIN/AEI/ 10.13039/501100011033, Consejería de Educación (Project SA093P20), and Strategic Research Programs for Units of Excellence from Junta de Castilla y León (ref. CLU-2018-04). Lidia Garzón-García was financed by Grant PRE2020-095876 associated to the project MCIN/AEI/ 10.13039/501100011033 and by “ESF Investing in your future”. Financiadores National Institutes of Health United States P40 OD010440 European Social Fund Plus European Union Consejería de Educación, Junta de Castilla y León Spain SA093P20es_ES


Fichier(s) constituant ce document

Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Attribution-NonCommercial-NoDerivatives 4.0 Internacional